Ludwig Cancer Research (CH)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
122
Publications
395
Citations
188927
i10-index
231
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Hallmarks of Cancer: The Next Generation | 2011 | 66266 |
The Hallmarks of Cancer | 2000 | 28888 |
Studies on transformation of Escherichia coli with... | 1983 | 11274 |
Patterns and Emerging Mechanisms of the Angiogenic... | 1996 | 6932 |
The consensus molecular subtypes of colorectal can... | 2015 | 5165 |
Accessories to the Crime: Functions of Cells Recru... | 2012 | 4638 |
Modes of resistance to anti-angiogenic therapy | 2008 | 2949 |
Matrix metalloproteinase-9 triggers the angiogenic... | 2000 | 2806 |
Antiangiogenic Therapy Elicits Malignant Progressi... | 2009 | 2344 |
Subtypes of pancreatic ductal adenocarcinoma and t... | 2011 | 1963 |
Douglas Hanahan is a researcher with 395 publications and 188927 citations. They are affiliated with Ludwig Cancer Research. Their research focuses on . With an h-index of 122, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Douglas Hanahan and 250M+ other papers.
Citations per publication by year